Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections
- PMID: 3246212
Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections
Abstract
This study reports the results of long-term (24 weeks) low-dose prophylaxis in 26 young female patients suffering from recurrent uncomplicated urinary tract infection (UTI). The patients were randomized in a double-blind manner to treatment with 100 mg trimethoprim (TMP, 12 patients) or 500 mg cinoxacin (CNO, 14 patients) at bedtime. The duration of prophylaxis in the TMP group was 2016 and in the CNO group 2352 days. Blood chemistry, haematological and urinary parameters were closely monitored during treatment and the latter were followed for a further 4-6 weeks. The prophylactic efficacy of the drugs was equal and significant (p less than 0.05). In the TMP group one recurrence and in the CNO group two recurrences occurred during treatment, two recurrences being observed in each group during the follow-up period of 4-6 weeks. Trimethoprim is well documented and widely used; cinoxacin provides a new alternative for long-term prophylaxis.
Similar articles
-
Comparison of low-dose cinoxacin therapy and placebo in the prevention of recurrent urinary tract infections.J Fam Pract. 1982 Nov;15(5):901-4. J Fam Pract. 1982. PMID: 6752331 Clinical Trial.
-
Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.Am J Med. 1987 Apr 27;82(4A):284-7. Am J Med. 1987. PMID: 3555049 Clinical Trial.
-
Cinoxacin and trimethoprim with sulfamethoxazole in the treatment of infections of the urinary tract: a clinical comparison.J Am Osteopath Assoc. 1982 Aug;81(12):843-5. J Am Osteopath Assoc. 1982. PMID: 7129972 No abstract available.
-
A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections.Curr Med Res Opin. 2007 Oct;23(10):2415-22. doi: 10.1185/030079907X233089. Curr Med Res Opin. 2007. PMID: 17723159 Review.
-
Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.Drugs. 1983 Jun;25(6):544-69. doi: 10.2165/00003495-198325060-00002. Drugs. 1983. PMID: 6347618 Review.
Cited by
-
Antibiotics for preventing recurrent urinary tract infection in non-pregnant women.Cochrane Database Syst Rev. 2004;2004(3):CD001209. doi: 10.1002/14651858.CD001209.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266443 Free PMC article.
-
State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women.Clin Infect Dis. 2025 Mar 17;80(3):e31-e42. doi: 10.1093/cid/ciae653. Clin Infect Dis. 2025. PMID: 40095960 Review.
-
Antibiotics for Preventing Recurrent Urinary Tract Infection: Systematic Review and Meta-analysis.Open Forum Infect Dis. 2022 Jul 3;9(7):ofac327. doi: 10.1093/ofid/ofac327. eCollection 2022 Jul. Open Forum Infect Dis. 2022. PMID: 35899289 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical